FACT SHEET v1.0 · May 2026
Cancer Series

Advanced kidney cancer: the essentials

Your kidney cancer has spread, or your team is worried it will. This is serious, and treatment has changed a lot since 2018. Many people now live for years on the new drugs, and a smaller group has a long-lasting response.

1 in 4
People with kidney cancer have spread when first found.
4+ years
Average survival on today's combination drugs, across recent trials.
4
First-line drug combinations are standard of care today.

Older numbers do not fit you

Survival numbers online mostly come from before 2018, collected before today's drugs were in wide use. Ask your team for current numbers for your situation.

Your IMDC risk group guides the plan

Your team uses the IMDC score, from the International Metastatic renal cell carcinoma (RCC) Database Consortium, to sort you into one of three groups using six lab and health factors. The group points to which drug combination fits best. Ask: "What is my IMDC risk group?"

Favorable
0 of 6
None of the six factors. Often slower-growing. Best outlook.
Intermediate
1 to 2
Most common group. Combination treatment works well here.
Poor
3 or more
More aggressive on average. Combination still helps.
The four first-line combinations

Pembrolizumab + axitinib

Immune drug by IV plus a pill twice a day. Works across all risk groups. Steady response.

Nivolumab + cabozantinib

Immune drug by IV plus a pill once a day. The pill has activity in bone and brain spots.

Pembrolizumab + lenvatinib

Strongest early response of the four. The pill is most likely to need dose changes.

Nivolumab + ipilimumab

Two immune drugs together. Used for intermediate or poor risk. More side effects up front. Highest chance of a long, deep response.

What to watch for on treatment

Track your blood pressure

The pill side, a tyrosine kinase inhibitor (TKI), raises blood pressure for many people. Home blood pressure readings help your team adjust the dose, so let them know if your numbers run high.

Tell your team about side effects

A lower dose you can stay on works better than a full dose you have to stop. Dose changes are a normal part of treatment.

Carry an immunotherapy wallet card

It tells any ER doctor you are on a checkpoint inhibitor. Steroids and timing change in this group.

Ask about palliative care early

Palliative care runs alongside cancer treatment. It is not hospice. It helps with pain, sleep, mood, and family talks.

Dental check before bone drugs

If you are starting zoledronic acid or denosumab for bone spots, see a dentist first. Treat any active dental problem.

Ask about fertility

If you might want children, ask about sperm or egg banking before treatment starts. There is only a short window to do this.

The kidney does not always come out first

For many people with spread, drug treatment now starts first. The kidney comes out later only if there is a clear reason. If you were told the kidney must come out right away, ask whether starting drug treatment first is also reasonable.

Questions to bring to your next visit
  • What is my IMDC risk group, and how does that shape what you are recommending?
  • Which of the four first-line combinations do you recommend for me, and why?
  • Has my case been reviewed at a tumor board?
  • Should I see a high-volume kidney cancer center for a second opinion?
  • Are there clinical trials open for me at this stage?
  • What does my pathology report say? Can I have a copy?

Go to the ER

  • You have chest pain
  • You are having severe trouble breathing
  • You get severe belly pain with a fever
  • You are bleeding heavily
  • Weakness starts on one side of your body
  • You have a bad headache with vomiting
  • You have a seizure
  • You cannot think clearly
  • You have severe back pain with leg weakness, or new bowel or bladder changes. This can mean the spinal cord is being pressed. It is an emergency.

Call your team the same day

  • A rash is spreading
  • You have diarrhea or blood in your stool
  • You get a new cough or trouble breathing
  • You feel severely tired and dizzy
  • You have new joint pain
  • A new headache or vision change starts
  • Your blood pressure runs much higher than usual
  • Your bone pain is new or much worse

Want the full picture?

This is the short version. For risk groups, the four combinations side by side, side-effect detail, second-line drugs, and questions for your team, see the Kidney Cancer (Advanced) Patient Guide.